Product Images Divalproex Sodium

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 6 images provide visual information about the product associated with Divalproex Sodium NDC 70518-2665 by Remedyrepack Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Remedy_Label - Remedy Label

Remedy_Label - Remedy Label

Divalproex Sodium Delayed-release 125mg Tablets in a pack of 30. Manufactured by Sun Pharma in Cranbury, NJ. To be used as directed and kept out of reach of children. Store between 20-26°C (63-77°F). See package insert for directions. The product was repackaged by Remedy Repack Inc in Indiana.*

spl-divalproex-figure-1 - spl divalproex figure 1

spl-divalproex-figure-1 - spl divalproex figure 1

The text appears to be a label for a figure with the title "Figure 1". It includes abbreviations for "PBO" and "DVPX", followed by the names of two different studies ("Study 1" and "Study 2") with acronyms for the scales used during each study ("YMRS" and "MRS" respectively). Without additional context, it is not clear what the abbreviations or studies refer to specifically.*

spl-divalproex-figure-2 - spl divalproex figure 2

spl-divalproex-figure-2 - spl divalproex figure 2

This appears to be a graph depicting the results of a study or experiment. The x-axis shows the percentage of patients, while the y-axis displays the reduction in CPS rate (possibly a measure of pain). The graph includes two lines, one labeled "DVPX" and the other "Placebo." The chart seems to show that DVPX had a greater positive effect on patients than the Placebo, with more patients experiencing improvement rather than worsening. However, without additional context or information, the specifics of the study or experiment and its implications cannot be determined.*

spl-divalproex-figure-3 - spl divalproex figure 3

spl-divalproex-figure-3 - spl divalproex figure 3

spl-divalproex-figure-4 - spl divalproex figure 4

spl-divalproex-figure-4 - spl divalproex figure 4

The text provides a description of Figure 4 displaying the average 4-week migraine rates for two different treatments, namely Placebo and DVPX in two different studies, Study 1 and Study 2.*

spl-divalproex-structure - spl divalproex structure

spl-divalproex-structure - spl divalproex structure

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.